Ovarian stimulation with FSH reduces phosphorylation of gonadotrope progesterone receptor and LH secretion in the rat by Gordon, Ana et al.
REPRODUCTIONRESEARCHOvarian stimulation with FSH reduces phosphorylation of
gonadotrope progesterone receptor and LH secretion in the rat
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AdministrationofhumanFSH (hFSH) tocyclic rats during thedioestrous phase attenuatesprogesterone receptor (PR)-dependenteventsof the
preovulatory LH surge in pro-oestrus. The increased bioactivity of the putative ovarian gonadotropin surge inhibiting/attenuating factor
induced by hFSH treatment is not associated with a decrease in PR protein expression, and the possibility of its association at a PR
posttranslational effect has been raised. The present experiments aimed to analyse PR phosphorylation status in the gonadotrope of rats with
impaired LH secretion induced by in vivo hFSH injection. Two experimental approaches were used. First, incubated pro-oestrous pituitaries
from hFSH-injected cycling and oestrogen-treated ovariectomized (OVX) rats were used to analyze the effect of calyculin, an inhibitor of
intracellular phosphatases, on PR-dependent LH release, which was measured in the incubation medium by RIA. Second, pituitaries taken
from hFSH-injected intact cycling and OVX rats and later incubated with P or GNRH1 were used to assess the phosphorylation rate of
gonadotrope. The latter was analysed in formalin-fixed, paraffin-embedded tissue sections by immunohistochemistry using a MAB that
recognizes the phosphorylated (p) form of PR at Ser294. Calyculin reduced the ovary-mediated inhibition of hFSH in GNRH1-stimulated LH
secretion. In addition, the immunohistochemical expression of pSer294 PRwas significantly reduced after ovarian stimulation with hFSH in
pituitaries frompro-oestrous rats incubatedwithPorGNRH1.Altogether, these results suggested that the ovarian-dependent inhibitoryeffect
of FSH injection on the preovulatory LH secretion in the rat may involve an increase in dephosphorylation of PR.
Reproduction (2009) 137 151–159Introduction
In the rat, exogenous FSH increases and/or prolongs the
bioactivity (secretion and/or action) of putative gonado-
tropin surge inhibiting/attenuating factor (GnSI/AF; de
Koning 1995, Fowler et al. 2003, Messinis 2006), a non-
steroidaland non-inhibinovarian factor (Fowleretal. 1993,
2003, Byrne et al. 1995). GnSI/AF negatively regulates
GNRH1-stimulated LH secretion (Tijssen et al. 1997) and
GNRH1 self-priming (Koppenaal et al. 1991, Fink 1995).
These two events depend on gonadotrope progesterone
receptor (PR; Chappell et al. 1999, Gordon et al. 2008).
The mechanism of action of GnSI/AF is largely unknown
(Fowler & Templeton 1996, Messinis 2006), although some
data are available. Thus, GnSI/AF neutralizes downstream
actions of second messengers involved in GNRH1 self-
priming (Fowler&Templeton1996,Tijssenet al. 1997), and
this action is associated with a blockade of gonadotrope PR
action (Byrne et al. 1996) rather than with an inhibition of
PR expression (Gordon et al. 2008). The findings reported
by Gordon et al. (2008) also suggest that the inhibitory
influence of GnSI/AF on preovulatory LH secretion isq 2009 Society for Reproduction and Fertility
ISSN 1470–1626 (paper) 1741–7899 (online)exerted at gonadotrope PR posttranslational level. Phos-
phorylation is a posttranslational modification known to
modulate the activity of the hormone-activated transcrip-
tion factor PR (Denner et al. 1990, Faus & Haendler 2006),
which appears to occur at serine (Ser) residues exclusively
(Beck et al. 1992, Takimoto & Horwitz 1993).
Former studies from our group had shown that
membrane oestrogen receptor-initiated intracellular sig-
nalling enhances gonadotrope protein phosphatase
activity and results in the inhibition of GNRH1 self-
priming (Sánchez-Criado et al. 2006, Garrido-Gracia et al.
2007). The aim of the present study was to analyse PR
phosphorylation status in the gonadotrope of rats with
impaired LH secretion induced by GnSI/AF. For this
purpose, the biological activity of endogenous GnSI/AF
was first increased in cycling rats by the administration of
FSH (Geiger et al. 1980, Koppenaal et al. 1991, Culler
1992). Then, pro-oestrous pituitaries from these rats were
used to analyse the following: first, the in vitro effect of
calyculin, a potent inhibitor of intracellular phosphatases
(Condrescu et al. 1999), on GNRH1-stimulated LHDOI: 10.1530/REP-08-0318
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152 A Gordon and otherssecretion and GNRH1 self-priming, and second, the
in vitro effect of ligand-dependent and -independent
activators of PR on the immunohistochemical (IHC)
expression of PR phosphorylated at the Ser residues level.Results
Effects of human FSH (hFSH) treatment on vaginal
cytology, uterine ballooning and serum 17b-oestradiol
(E2) concentration in intact cycling and OVXCoestra-
diol benzoate (EB) rats
Details of the incubation protocols used are given in the
Materials and Methods and summarized Fig. 1. On day
4, vaginal smears from intact cycling and OVXCEB rats
treated or not with hFSH displayed nuclear epithelial/
cornified cells characteristic of vaginal pro-oestrus. Also,
uteri were ballooned to a similar extent in all four groups
of rats. However, differences in E2 serum concentrations
were noted. Whereas treatment with hFSH increased
significantly serum E2 levels in intact cycling rats,
treatment with hFSH did not increase serum E2
concentrations in OVXCEB rats (Fig. 2).Effects of hFSH treatment on GNRH1-, phorbol
12-myristate 13-acetate (PMA)-, forskolin (FSK)-,
calyculin A- and ionomycin-induced LH secretion in
intact cycling and OVXCEB rat pituitaries
Pituitaries from pro-oestrous cycling rats injected with
saline exhibited increased LH secretion in response to
GNRH1; GNRH1 self-priming; and PMA, FSK and
calyculin potentiation of GNRH1-stimulated LH
secretion (Fig. 3). In contrast, pituitaries from intactFigure 1 Diagram showing the pituitary incubation protocol used in each of
(OVX)Coestradiol benzoate (EB)Csaline or hFSH (see the Materials and Me
medium (M) alone, hemipituitaries from the four groups of rats were incub
15 min of the 75-min incubation period (arrow) was used to determine (A) ba
priming, (D) PRKCC potentiation of GNRH1-stimulated LH secretion, (E) PR
(calyc) effect on GNRH1-stimulated LH secretion and (G) CaCC-dependen
10K7 M of the PRKCC activator phorbol 12-myristate 13-acetate; FSKZ5!1
the inhibitor of intracellular phosphatases calyculin A; ionoZ5!10K5 M o
Reproduction (2009) 137 151–159cycling rats treated with hFSH did not display a significant
increase in LH secretion in response to GNRH1, PMA and
FSK with respect to LH secretion from pituitaries
incubated with medium alone. Calyculin at the dose of
10K7 M significantly increased GNRH1 pituitary respon-
siveness in pituitaries from hFSH-treated intact cycling
rats (Fig. 3). Moreover, this increasing effect of calyculin
on GNRH1-stimulated LH secretion was demonstrated to
be dose-dependent (Fig. 4). The addition of the CaCC
ionophore ionomycin to the incubation medium resulted
in a massive release of LH in pituitaries from cyclic rats
injected with saline but not in pituitaries from cyclic rats
injected with hFSH. No differences were found in LH
secretion between calyculinCGNRH1 and ionomycin in
intact cycling rats treated or not with hFSH. No
differences for any LH secretion parameter were noted
on day 4 between pituitaries from OVXCEB rats whether
or not treated with hFSH (Fig. 3).Effect of hFSH treatment on pituitary LH content in
intact cycling and OVXCEB rats
Treatment with hFSH decreased pro-oestrous pituitary
LH content in intact cycling rats. This inhibitory effect of
hFSH on pituitary LH content was not observed in
OVXCEB rats on day 4 (Fig. 5).Effect of FSH treatment on pituitary PR10A9 expression
in intact cycling and OVXCEB rats
No significant effect of hFSH was found in the number of
PR10A9-positive cells in either intact cyclic or OVXCEB
rats (Figs 2 and 6A). The number of PR10A9-positivethe four groups of rats: intact cyclingCsaline or hFSH, ovariectomized
thods section for details of treatments). After 1 h of pre-incubation with
ated for a 75-min period. Medium accumulation of LH during the last
sal LH secretion, (B) GNRH1-stimulated LH secretion, (C) GNRH1 self-
KACA potentiation of GNRH1-stimulated LH secretion, (F) calyculin A
t LH secretion. GNRH1Z10K8 M LH-releasing hormone; PMAZ
0K5 M of the activator of adenylyl cyclase forskolin; calycZ10K7 M of
f the CaCC ionophore ionomycin.
www.reproduction-online.org
Figure 2 Effect of hFSH treatment on serum 17b-oestradiol (E2)
concentrations (pmol/l serum) and the number of pituitary PR10A9-
positive cells/field 40! at 0900 h on day 4 (pro-oestrus in intact cycling
rats) and in OVX rats injected with EB (see the Materials and Methods
section for details of treatments). Values are meansGS.E.M. of eight rats.
aP!0.05 versus intact cyclic ratsCsaline (ANOVA and Student–
Newman–Keuls multiple range test).
Figure 3 Effect of hFSH treatment on LH release to the medium
(ng/hemipituitary) during the last 15 min of incubation by pituitaries
from: intact cycling or OVX rats injected with EB (see the legend of
Fig. 1 for details of treatments). Values are meanGS.E.M. of eight
hemipituitaries. aP!0.05 versus pituitaries incubated with medium (M)
alone, and bP!0.05 versus GNRH1-stimulated LH secretion ANOVA
and Student–Newman–Keuls multiple range test. Priming and primed:
test substances during the first 60 min or the last 15 min of the
incubation period respectively.
FSH reduces LH secretion and PR phosphorylation 153pituitary cells in OVXCEB rats was significantly higher
than that in intact cycling rats (Fig. 2). A high correlation
(rZ0.987; yZ0.01xC8.91) was found between serum E2
concentrations and the number of PR10A9-positive
pituitary cells.Pituitary pSer294 expression in pro-oestrous
cycling rats
Immunoreactive products to pSer294 MAB, diluted
1:300, were observed in the nuclei of some pituitary
cells (Fig. 6). The number of pSer294-positive cells was
higher in pituitaries incubated for 1 or 2 h either with P or
GNRH1 than in those incubated with medium alone
(Figs 6B and 7). This effect, which was more evident in
pituitaries incubated with the cognate ligand (the effect
of P was about threefold higher than that of GNRH1),
was demonstrated to be dose dependent (Fig. 7).www.reproduction-online.orgEffect of hFSH treatment on P- and GNRH1-induced
pSer294 expression in intact cycling and in OVXCEB
rat pituitaries
The number of cells expressing pSer294 was significantly
reduced in pituitaries from hFSH-treated cycling rats
incubated either with P or GNRH1. In contrast, the
number of gonadotropes expressing pSer294 was not
affected by hFSH in OVXCEB rats injected regardless of
incubation conditions (Fig. 8).Discussion
The results of the present study showed that the putative
ovarian GnSI/AF action on PR-dependent LH secretion in
pro-oestrous rats was associated with an increase in
gonadotrope PR dephosphorylation. In physiological
conditions, the bioactivity of GnSI/AF is expressed in
dioestrus (Tijssen et al. 1997), but it is prolonged up to
pro-oestrus under the influence of exogenous FSHReproduction (2009) 137 151–159
Figure 4 Dose-dependent sensitization effect of calyculin to GNRH1 in
pituitaries from intact cycling or OVXCEB rats injected with hFSH (see
the Materials and Methods section and legend of Figs 1 and 3 for details
of treatments). Values were expressed as the percentage of LH release
from controls (pituitary LH release from intact cyclic or OVX rats
injected with saline). Values are meanGS.E.M. of eight hemipituitaries.
ANOVA and Student–Newman–Keuls multiple range test. aP!0.05
versus LH release without calyculin.
Figure 5 Pituitary LH content (mg/mg protein) on day 4 in intact cycling
and OVXCEB rats injected with hFSH or saline (see the Materials and
Methods section and legend of Fig. 1 for details of treatments). Values
are meanGS.E.M. of eight pituitaries. ANOVA and Student–Newman–
Keuls multiple range test. aP!0.05 versus intact cycling.
154 A Gordon and others(present results). These facts are in agreement with
previous results showing that the decrease in serum FSH
concentration during dioestrus reduces and/or shortens
GnSI/AF bioactivity and advances the preovulatory LH
release in cyclic rats by 1 day (Tebar et al. 1998). Overall,
the present results suggested that PR dephosphorylation
was involved in the ovary-mediated FSH inhibitory effect
on GNRH1-stimulated LH secretion (Tijssen et al. 1997).
The inhibitor of intracellular phosphatases calyculin
sensitized only in part the incubated pituitaries from intact
cyclingpro-oestrous rats injectedwithhFSHto the releasing
action of GNRH1. In contrast, calyculin fully primed the
incubated pituitaries collected from saline-injected intact
cycling pro-oestrous rats, as well as those collected from
OVXCEB rats, to the releasing action of GNRH1 regardless
of whether they were treated or not with hFSH. Pituitaries
collected from pro-oestrous rats treated with hFSH had low
pituitary responsiveness to well-known secretagogue and
priming phosphorylating agents (GNRH1, PRKCC and
PRKACA). This was also observed in a previous report from
our laboratory in which the potentiating effect of the
cognate phosphorylating ligand P on GNRH1-stimulated
LH secretion was found to be absent in hFSH-treated cyclic
rats (Gordon et al. 2008). OVX reversed all inhibitoryReproduction (2009) 137 151–159actions of hFSH on gonadotrope function (Gordon et al.
2008, present results). This effect of OVX indicated that the
inhibitory effects of hFSH on LH secretion were mediated
byan ovarian factor (de Koning et al. 1987, Balen 1996) that
was found to be non-steroidal in nature (Fowler et al. 2003,
Messinis 2006). As calyculin inhibits phosphatase-induced
dephosphorylation, these findings seemed to indicate that
the putative GnSI/AF produces an imbalance of phos-
phorylase/phosphatase activities on gonadotrope PR, limit-
ing the magnitude of the PR-dependent LH secretion. In
addition, lower LH synthesis may also exist in intact cycling
rats injected with hFSH. This is because treatment with
hFSH reduced pituitary LH content in intact cycling rats but
not in OVX rats. Furthermore, the CaCC ionophore
ionomycin induced, as expected, a vast LH exocytosis in
pituitaries from all experimental groups, except for
pituitaries from intact cycling rats given hFSH, in which
LH exocytosis was only modest.
In rats injected with hFSH, non-steroidal ovarian
substances inhibin (Ying 1988) and GnSI/AF (Messinis
2006) are ovarian factors probably involved in the
attenuation of the preovulatory LH surge (Culler 1992).
However, accumulated evidence indicates that GnSI/AF is
different from inhibin in many respects (Scott & Burger
1981, de Koning et al. 1987, Balen et al. 1995, Fowler et al.
2003). In this regard, the findings by Ishigame et al. (2004)
are of interest because they show attenuated LH surges
in rats after ovarian stimulation with FSH in the absence of
bioactive inhibin. As a matter of fact, the negative feedback
of ovarian inhibin on FSH release is via interaction with
a specific receptor at the gonadotrope membranewww.reproduction-online.org
Figure 6 Immunohistochemical (IHC) expression of progesterone
receptors (PR) and phosphorylated PR in anterior pituitary cells.
(A) Immunoreactive products to PR10A9 antibody are seen in the nuclei
of some cells from pituitaries incubated with medium alone. (B) Also,
immunoreactive products to pSer294 antibody are observed in the
nuclei of cells from pituitaries incubated with 10K6 M progesterone
over two hours, (C) but not with medium alone. Note that the number of
phosphorylated PR is lower (B) than the number of PR (A). See the lower
panel of Fig. 2 for the total number of E2-dependent pituitary PR10A9-
positive cells and Fig. 8 for ligand-dependent and -independent
pituitary pSer294-positive cells in the four groups of rats. ABC method.
Figure 7 Ratio of pSer294/PR10A9-positive cells in pro-oestrous
pituitaries from cycling rats after incubation over 60 or 120 min with
medium alone or with different doses of progesterone (P) or GNRH1.
See the Materials and Methods section for details. Values are
meanGS.E.M. of three pituitaries. ANOVA and Student–Newman–Keuls
multiple range test. aP!0.05 versus medium, bP!0.05 versus GNRH1,
and cP!0.05 versus P 10K7 M.
FSH reduces LH secretion and PR phosphorylation 155(Robertson et al. 2000), and involves inhibition of both
secretion and synthesis of FSH (Scott & Burger 1981,
Attardi et al. 1991). Similarly, the GnSI/AF acting on
specific gonadotrope membrane receptors different from
GNRH1 receptors (Fowler & Templeton 1996) reduced
preovulatory LH secretion and pituitary LH synthesis.www.reproduction-online.orgThe balance between the activitiesof protein kinases and
phosphatases (Weigel & Moore 2007) is the most common
posttranslational processing event of PR (Faus & Haendler
2006). Thus, phosphorylation seemed to be involved in
PR-regulated gene transcription (Denner et al. 1990,
Moore et al. 2007). Studies on PR (Beck et al. 1992,
1996) indicate that only Ser residues are phosphorylated
(Takimoto & Horwitz 1993), and that Ser294 phosphoryl-
ation is strongly hormone dependent (Moore et al. 2007).
The cognate agonist and the intracellular messengers of
GNRH1 (Denneretal. 1990, Baiet al. 1997)phosphorylate
Ser294 and induce PR-mediated transcription (Zhang et al.
1994), expression of PR-dependent GNRH1 self-priming
proteins (Fink 1995, Tijssen et al. 1997), preovulatory LH
secretion (Fink 1988; Fig. 9) and PR down-regulation
(Lange et al. 2000). We have standardized the IHC method
for the detection of PR with a phosphorylated Ser
residue at position 294 in rat pituitaries. The antibody
pSer294 recognizes the immunogen corresponding toReproduction (2009) 137 151–159
Figure 8 Effect hFSH treatment (see the Materials and Methods section
and the legend of Fig. 1 for details of treatment) in intact cycling or OVX
rats injected with EB in the ratio of pSer294/PR10A9-positive cells in
pituitaries incubated for 2 h with medium alone or 10K6 M
progesterone (P) or 10K7 M GNRH1. See the legend of Fig. 7 and the
Materials and Methods section for details of positive cells counting.
ANOVA and Student–Newman–Keuls multiple range test. aP!0.05
intact cycling rats injected with saline.
156 A Gordon and othersamino acid residues 288–300 from human PR with Ser294
being phosphorylated, P(288)MAPGRS(p)PLATTV(300)
(Clemm et al. 2007). PR alignment revealed an almost
full-sequence homology of amino acid residues between
the human immunogen and rat PR: P(286)-
VAPGRSPLATTV(298). The effect of different phosphor-
ylating agents on incubated pituitarieswas expressed as the
percentage of PR (PR10A9)-positive pituitary cells expres-
sing pSer294 immunoreactive products. In the rat,
gonadotropes are the only pituitary cell type expressing
PR (Fox et al. 1990, Turgeon & Waring 2000, Sánchez-
Criado et al. 2004), and the present experiments showed a
high correlation between E2 serum levels and the number
of pituitary PR10A9 immunoreactive cells. Our results also
showed that gonadotropes exhibited a low PR phosphoryl-
ation rate (pSer294 expression) in the absence of P or
GNRH1 in the incubation medium, while both P andFigure 9 Schematic showing the proposed interrelationship of the cellular a
progesterone receptor (PR) activity and LH release. At the pituitary level, E2
priming effects, induces PR expression. These PR become activated/phospho
PRKCC and PRKACA. Also at the pituitary level, E2 activates gonadotrope mem
latter can also be activated by GnSI/AF (present paper). The balance betwee
transcription of priming proteins, GNRH1 self-priming and LH surge.
Reproduction (2009) 137 151–159GNRH1 induced pSer294 immunoreactivity in a dose- and
time-dependent manner. This ligand-dependent and
-independent phosphorylation of gonadotrope PR was
significantly reduced in pituitaries from rats undergoing
the ovary-mediated inhibitory action of hFSH. Similarly, it
has been shown that treatment with alkaline phosphatases
inhibits PR phosphorylation in T47D cells (Takimoto &
Horwitz 1993). Finally, PR is expressed as two isoforms:
PR-A and PR-B (Kastner et al. 1990). While PR-B is the
stronger transcriptional activator isoform of PR, PR-A is
a modulatory isoform of PR-B action (Kazmi et al. 1993).
As the antibody pSer294 has preferential affinity for PR-B
(Moore et al. 2007, Weigel & Moore 2007), results of the
present study suggest that the deficient phosphorylation/
activation of PR-B isoform could be a probable causative
factor of the ovary-mediated hFSH-induced attenuation of
LH secretion (Fig. 9).
In conclusion, the results suggested that the inhibitory
effect of the FSH-dependent putative ovarian bioactive
GnSI/AF on the preovulatory LH secretion in the rat may
be due to dephosphorylation of gonadotrope PR.Materials and Methods
Animals
General conditions and surgery
Adult female Wistar rats weighing 190–210 g were housed
under a 14 h light:10 h darkness cycle (lights on at 0500 h) and
22G2 8C room temperature, with access to rat chow and tap
water ad libitum. Rats were included in the experiments after
showing at least three consecutive 4-day regular oestrous cycles.
Vaginal smears were taken 6 days/week and the day of vaginal
oestrus was arbitrarily considered as day 1. Bilateral ovariectomy
(OVX) was performed under light ether anaesthesia at 0900 h on
day 2 of the cycle. Rats were decapitated at 0900 h on day 4; theirnd molecular components that may be involved in the regulation of
activates nuclear (n) ESR1 and nESR2 which, in addition to many other
rylated by P and/or the E2-dependent GNRH1-intracellular messengers
brane (m) ESR1, which increases intracellular phosphatases activity. The
n intracellular kinases and phosphatases activities elicits PR-dependent
www.reproduction-online.org
FSH reduces LH secretion and PR phosphorylation 157pituitary glands removed, separated from the neural lobe, divided
in halves and assigned to incubation, pituitary LH content or IHC
studies. All experimental protocols were approved by the Ethical
Committee of the University of Córdoba, and experiments were
performed in accordance with rules on laboratory animal care
and international law on animal experimentation.Treatment with hFSH
Recombinant hFSH (Gonal-f; Serone, Aubonne, Switzerland)
was dissolved at a concentration of 50 IU/ml saline and 10 IU
hFSH was given s.c. at 1400 h on day 2 and at 0900 h on day 3
(Gordon et al. 2008). This dose of hFSH derives from the results
of previous experiments (Gordon et al. 2008). Non-stimulated
controls were given 0.2 ml saline. Groups of rats treated with
hFSH included intact cycling rats (intact cyclingChFSH) and
ovariectomized (OVX) rats treated with EB (OVXCEBChFSH).
OVX rats were given 5 and 10 mg EB/0.2 ml oil at 1400 h on day
2 and at 0900 h on day 3 respectively (Schuiling et al. 1999).Rat pituitary incubation studies
General incubation protocol of rat pituitaries
Incubation of pituitaries was carried out, with minor modifi-
cations, as described previously (Gordon et al. 2008). Briefly,
hemipituitaries were divided into quarters (Knox & Schwartz
1993) and incubated at 37 8C with constant shaking
(60 cycles/min) in an atmosphere of 95% O2 and 5% CO2.
Each incubation vial contained 250 ml Dulbecco’s modified
medium without L-glutamine and phenol red and containing
glucose (4.5 g/l), 10K8 M E2 (Sigma Chemical Co.) and BSA
(0.1% w/v, pH 7.4). After 1-h pre-incubation without test
substances, hemipituitaries were incubated for 75 min with
different test substances (Fig. 1). In the last 15 min, the medium
was removed for the determination of LH concentration and
pituitary responsiveness (Fig. 1). Doses of hormones and drugs
used and timing of treatments derive from previous papers
(Denner et al. 1990, Turgeon & Waring 1991, Sánchez-Criado
et al. 2004, 2006, Gordon et al. 2008).Effects of hFSH treatment on GNRH1-, PMA-, FSK-, calyculin
A- and ionomycin-induced LH secretion in intact cycling and
OVXCEB rat pituitaries
Hemipituitaries of the four groups of animals (intact cycling
ChFSH, intact cyclingCsaline, OVXCEBChFSH and OVX
CEBCsaline) were incubated (see general incubation protocol)
with different test substances (Fig. 1). Test substances included
were: 10K8 M GNRH1 (Peninsula 7201, Peninsula Lab. Inc.,
Merseyside, UK), 10K7 M of the PRKCC activator PMA (Sigma),
5!10K5 M of the activator of adenylyl cyclase FSK (Sigma) and
10K7 M calyculin A (Sigma), an inhibitor of intracellular
phosphatases (Marantz et al. 1995, Condrescu et al. 1999).
Whereas PMA, FSK and calyculin A were present during the
entire 75-min incubation period, GNRH1 challenge was present
during the first 15 min only (Fig. 1). Except for hemipituitaries
incubated with medium alone and ionomycin, fresh medium
containing the corresponding test substance (medium, PMA, FSKwww.reproduction-online.orgor calyculin) plus GNRH1 was added during the last 15-min
period. Finally, to evaluate the secretory capacity of the
gonadotropes, hemipituitaries from intact cyclingCsaline, intact
cyclingChFSH, OVXCEBCsaline and OVXCEBChFSH rats
were incubated with 5!10K5 M of the ionophore ionomycin
(Sigma) during the 75-min incubation period. Additional
hemipituitaries from the four experimental groups of rats were
incubated in the presence of increasing doses of calyculin (0,
10K8, 10K7 and 10K6 M) during the 75-min incubation period
and challenged with GNRH1 during the last 15 min of
incubation. Values in this last experiment were expressed as the
percentage of LH release from controls (pituitary LH release from
cyclic or OVXCEB rats injected with saline).
Concentrations of LH in incubation media were measured in
duplicate by RIA using a double-antibody method with kits
supplied byNIH (Bethesda, MD, USA)andapreviouslydescribed
microassay method (Sánchez-Criado et al. 1990, Garrido-Gracia
et al. 2007). Rat LH-I-10 was labelled with 125I by the chloramine-
T method (Greenwood et al. 1963). All media samples were
assayed in the same test. The intra-assay coefficients of variation
were 8%. Assay sensitivity was 3.75 pg/tube. Results are
expressed as ng/hemipituitary of the RP LH-rat-RP-3.Effect of hFSH treatment on anterior pituitary LH
content and E2 serum levels
Anterior pituitaries from the four groups of animals were obtained
at 0900 h on day 4 to evaluate the LH content by RIA and the
protein content by the Bradford method (Bradford 1976) using the
Quick Start Bradford protein assay (Bio-Rad Laboratories, Inc).
Trunk blood was obtained from these rats, allowed to clot,
centrifuged and the serum stored atK20 8C until quantified for E2.
PituitaryLHcontent wasmeasured in duplicateby theRIA method
described above. Results are expressed as mg/mg pituitary protein.
Serum E2 concentrations were determined in duplicate using
a commercially obtained kit (Abbott Diagnostic Division). The
sensitivity of the assay was 10 pg/ml, and the intra-assay
coefficient of variation was 7%. E2 concentrations were
expressed as pmol/l serum.IHC studies of the PR phosphorylation status in rat
pituitaries
IHC expression of PR in gonadotropes
The commercial mouse monoclonal anti-human PR antibody
(PR10A9), raised against the recombinant hormone-binding
domain of human PR located in the C-terminal domain
(Kastner et al. 1990) of PR (Immunotech, Marseille, France),
diluted 1:15 000, was analysed using the avidin–biotin–
peroxidase complex (ABC) IHC method as described else-
where (Sánchez-Criado et al. 2004, 2006, Gordon et al. 2008).
The number of cells immunoreactive to PR10A9 antibody was
determined by counting all positive nuclei in 8–15 fields at a
magnification of 40! (high-power field, HPF) per tissue
section and expressed as the number of positive nuclei/HPF.
Four consecutive tissue sections were immunostained and
counted per pituitary.Reproduction (2009) 137 151–159
158 A Gordon and othersIHC expression of phosphorylated PR (phospho-PR-pSer294)
in gonadotropes
The commercial mouse monoclonal phospho-PR (pSer294)
antibody clone 608, raised against the immunogen
P(288)MAPGRS(p)PLATTV(300) located in the N-terminal
domain (Affinity BioReagents, Golden, CO, USA), diluted
1:300, was analysed using the ABC IHC technique (Vectastain,
ABC kit Elite, Vector Corporation, Burlingame, CA, USA). This
method was standardized in formalin-fixed, paraffin-embedded
pituitary tissue sections from rats in pro-oestrus under phosphor-
ylating conditions. For this purpose, three pituitaries/group from
pro-oestrous cycling rats were incubated over 1 or 2 h with
medium alone or with 10K7 and 10K6 M P (ligand-dependent
activator of PR) or 10K8 and 10K7 M GNRH1 (ligand-
independent activator of PR). Three additional pituitaries were
incubated with medium alone as PR phosphorylation negative
controls. Three different dilutions of pSer294 antibody were
assayed, 1:100, 1:300 and 1:500, and the final working dilution
of 1:300 was selected on the basis of the quality and specificity of
immunostaining (Fig. 6). Briefly, dewaxed and rehydrated 3 mm
thick tissue sections were subjected to high-temperature antigen
retrieval by incubation with 0.01 M citrate buffer (pH 6.0) at
95 8C for 8 min in a decloaking chamber (Biocare Medical,
Concord, CA, USA). All further IHC staining procedures were
according to the test kit instructions. Tissue sections were
counterstained with Mayer’s hematoxylin. The substitution of
specific primary antibody with non-immune mouse IgG1
(Affinity Bioreagents) in tissue sections of the pituitaries under
study were used as negative control in every assay.
Effect of hFSH treatment on the IHC expression of
phosphorylated PR (phospho-PR-pSer294) in gonadotropes
Three pituitaries from each of the four experimental groups of
rats were incubated for 2 h with 10K6 M P, 10K7 M GNRH1 or
medium alone. Concentrations and incubation times of P and
GNRH1 were selected on the basis of the IHQ standardization
protocol results.
The number of cells immunoreactive to pSer294 antibody
was determined similarly than PR10A9 antibody. The number
of PR phosphorylated at pSer294 was expressed as the
number of phosphorylated PR at Ser294 (pSer294-positive
cells)/number of PR-positive gonadotropes (PR10A9-positive
cells)!100. Eight consecutive tissue sections were immu-
nostained and counted per pituitary (even for PR10A9 and
odd for pSer294).Statistical analysis
Statistical analysis was performed by ANOVA to test for
significant differences among groups. When significant
differences existed, ANOVA was followed by the Student–
Newman–Keuls multiple range test to compare the means.
Significance was considered at the 0.05 level.Declaration of interest
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